Search

Displaying results 5841 - 5850 of 6073 in total
  1. Drug

    Canertinib

    go.drugbank.com/drugs/DB05424
    Investigational

    Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.

  2. Drug

    Bedoradrine

    go.drugbank.com/drugs/DB05590
    Investigational

  3. Drug

    PRX-03140

    go.drugbank.com/drugs/DB05596
    Investigational

  4. Drug

    OP-145

    go.drugbank.com/drugs/DB05672
    Experimental

    OP-145 is a synthetic antimicrobial peptide developed from human cathelicidin LL-37.

  5. Drug

    Perflubron

    go.drugbank.com/drugs/DB05791
    Investigational

    Perflubron (Oxygent) is being developed as an intravascular oxygen carrier designed to augment oxygen delivery in surgical patients.

  6. Drug

    Nelipepimut-S

    go.drugbank.com/drugs/DB06226
    Investigational

  7. Drug

    Caldaret

    go.drugbank.com/drugs/DB06231
    Investigational

  8. Drug

    Elsiglutide

    go.drugbank.com/drugs/DB06336
    Investigational

  9. Drug

    Elinogrel

    go.drugbank.com/drugs/DB06350
    Investigational

    A P2Y12 inhibitor and platelet aggregation inhibitor.

  10. Drug

    SPC2968

    go.drugbank.com/drugs/DB06351
    Investigational

    SPC2968 is a synthetic antisense oligodeoxynucleotide targeting hypoxia-inducible factor-1alpha (HIF-1alpha). It was under investigation in clinical trial NCT02564614 (A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic ...